文献速递消化道肿瘤与早癌消化内镜

液氮喷雾冷冻治疗晚期食管癌姑息治疗的前瞻性队列研究

Prospective cohort study of palliative treatment of esophageal cancer with liquid nitrogen spray cryotherapy.
PubMed 文献 · Gastrointest Endosc · 2026-01-16

该前瞻性队列研究纳入49例无法切除的梗阻性食管癌患者,重复液氮喷雾冷冻治疗(LNSC)后QLQ-C30评分平均改善1.7(95%CI 0.1-3.3),QLQ-OES18平均改善1.8(95%CI 0.4-3.3),吞咽困难序贯评分无显著改善;治疗总体耐受良好。

要点

  • 重复LNSC可小幅改善晚期食管癌患者整体及食管癌特异性生活质量评分。
  • 吞咽困难序贯评分未见显著改善,需结合其他姑息手段综合评估。
  • 仅4.1%患者出现可能相关不良事件,治疗总体耐受良好。

核心结论

  • LNSC对多数梗阻性食管癌患者的症状姑息和生活质量有持久且可重复的获益,且无需置入喂养管或食管支架。

研究设计与样本

  • 前瞻性队列试验,纳入49例无法切除的持续性食管癌患者,接受重复姑息性LNSC治疗,随访2年,采用重复测量和竞争风险分析。

主要发现

  • 每例患者QLQ-C30评分平均改善1.7(95%CI 0.1-3.3),QLQ-OES18平均改善1.8(95%CI 0.4-3.3)。
  • 每后续一轮治疗,QLQ-C30效应改善0.1(95%CI 0.3-0.4),QLQ-OES18恶化-0.2(95%CI -0.5至0.2)。
  • 吞咽困难序贯评分无显著改善。
  • 不相关严重不良事件常见(38.8%),仅2例(4.1%)出现可能相关事件(黑便和吞咽困难)。

临床怎么用

  • 对于无法切除的梗阻性食管癌,可考虑重复LNSC作为姑息治疗选项,以改善生活质量并减少喂养管或支架需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Palliation of dysphagia associated with advanced esophageal cancer is challenging. Previous studies suggest liquid nitrogen spray cryotherapy (LNSC) is effective in palliating obstructive esophageal cancer. We sought to prospectively examine the utility, safety, and efficacy of serial applications of repeated palliative LNSC in this population. METHODS: We performed a prospective cohort trial of LNSC for persistent esophageal cancer without the possibility of resection for palliation of obstructive symptoms. We used repeated measures and competing risks analyses to study the course of patients treated over 2 years. Efficacy of treatment was assessed using quality-of-life scores 14 days after treatment, using general cancer (Quality of Life Questionnaire [QLQ]-C30) and esophageal cancer-specific (QLQ-esophageal subset [OES]18) quality-of-life questionnaires, as well as ordinal dysphagia scores. Adverse events (AEs) were assessed using structured interviews and classified according to Common Terminology Criteria. RESULTS: On repeated treatments, each participant (N = 49) improved their QLQ-C30 score by a mean of 1.7 (95% CI, 0.1-3.3) and improved their QLQ-OES18 score by a mean of 1.8 (95% CI, 0.4-3.3). For each subsequent round of treatment, the effect improved 0.1 (95% CI, 0.3-0.4) for the QLQ-C30 score and worsened -0.2 (95% CI, -0.5 to 0.2) for the QLQ-OES18 score. There was no significant improvement in the ordinal dysphagia score. Nineteen (39.6%) of 48 participants with a feeding tube at baseline required a feeding tube or stent at a mean of 8 months. Although unrelated serious AEs were common (38.8%), only 2 patients had events possibly related to LNSC (4.1%, melena and dysphagia). CONCLUSIONS: Spray cryotherapy had a durable and repeatable benefit for palliation of obstructive symptoms of esophageal cancer and quality of life in the majority of patients, without the need for feeding tube or esophageal stent placement. Treatments were generally well tolerated.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Cotton CC, Eluri S, Kaul V, et al. Prospective cohort study of palliative treatment of esophageal cancer with liquid nitrogen spray cryotherapy. Gastrointest Endosc. 2026. PMID: 41548722. doi:10.1016/j.gie.2025.12.291

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。